These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31127950)

  • 1. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma.
    Koren A; Sprecher E; Reider E; Artzi O
    Br J Dermatol; 2020 Mar; 182(3):671-677. PubMed ID: 31127950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pachyonychia congenita with plantar injections of botulinum toxin.
    Swartling C; Vahlquist A
    Br J Dermatol; 2006 Apr; 154(4):763-5. PubMed ID: 16536826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases.
    González-Ramos J; Sendagorta-Cudós E; González-López G; Mayor-Ibarguren A; Feltes-Ochoa R; Herranz-Pinto P
    Dermatol Ther; 2016; 29(1):32-6. PubMed ID: 26445325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita.
    Swartling C; Karlqvist M; Hymnelius K; Weis J; Vahlquist A
    Br J Dermatol; 2010 Nov; 163(5):1072-6. PubMed ID: 20618323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
    Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
    Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking a day in a pachyonychia congenita patient's shoes: Impact on plantar pain and activity levels measured with wristband activity trackers.
    Lipner SR; Falotico JM; Matushansky JT; Evans H; Schwartz J; Hansen CD
    Indian J Dermatol Venereol Leprol; 2023; 89(6):850-853. PubMed ID: 37317732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
    Samuelov L; Smith FJD; Hansen CD; Sprecher E
    Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pachyonychia congenita in pediatric patients: natural history, features, and impact.
    Shah S; Boen M; Kenner-Bell B; Schwartz M; Rademaker A; Paller AS
    JAMA Dermatol; 2014 Feb; 150(2):146-53. PubMed ID: 24132595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCQoL: A Quality of Life Assessment Measure for Pachyonychia Congenita.
    Abbas M; Schwartz ME; Smith FJ; McLean WH; Hull PR
    J Cutan Med Surg; 2015; 19(1):57-65. PubMed ID: 25775665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute dysmenorrhoea and pelvic pain syndrome of uterine origin with myometrial botulinum toxin injections under hysteroscopy: A pilot study.
    Bautrant E; Franké O; Amiel C; Bensousan T; Thiers-Bautrant D; Levêque C
    J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101972. PubMed ID: 33186771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of high-resolution multifrequency ultrasound of the plantar skin in patients with various types of hereditary palmoplantar keratoderma.
    Goldberg I; Sprecher E; Schwartz ME; Gaitini D
    Dermatology; 2013; 226(4):365-70. PubMed ID: 24030314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A versus platelet rich plasma ultrasound-guided injection in the treatment of plantar fasciitis: A randomised controlled trial.
    Ruiz-Hernández IM; Gascó-Adrien J; Buen-Ruiz C; Perelló-Moreno L; Tornero-Prieto C; Barrantes-Delgado G; García-Gutiérrez M; Rapariz-González JM; Tejada-Gavela S
    Foot Ankle Surg; 2024 Feb; 30(2):117-122. PubMed ID: 37949704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Chen Y; Tsai CH; Bae TH; Huang CY; Chen C; Kang YN; Chiu WK
    Aesthetic Plast Surg; 2023 Apr; 47(2):775-790. PubMed ID: 36694050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder.
    Juszczak K; Adamczyk P; Maciukiewicz P; Drewa T
    Pharmacol Rep; 2018 Dec; 70(6):1133-1138. PubMed ID: 30317128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.